Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Delivery
Return to: PBR Home | Drug Research | Drug Delivery

Drug Delivery

Novo Nordisk launches Saxenda injection in US for weight management By PBR Staff Writer
Novo Nordisk has launched Saxenda (liraglutide [rDNA origin] injection), the first glucagon-like peptide-1 (GLP-1) receptor agonist for weight management in adults, in the US.
Drug Research > Drug Delivery > News
The Medicines Company gets FDA approval for new formulation of Minocin for injection By PBR Staff Writer
The Medicines Company (MDCO) has received approval from the US Food and Drug Administration (FDA) for its supplemental new drug application (sNDA) for a new formulation of Minocin (minocycline) for Injection.
Drug Research > Drug Delivery > News Merck submits sBLA to FDA for Keytruda to treat NSCLC By PBR Staff Writer
Merck has submitted a supplemental biologics license application (sBLA) to the US Food and Drug Administration (FDA) seeking approval for its anti-PD-1 therapy, Keytruda (pembrolizumab), to treat advanced non-small cell lung cancer (NSCLC).
Drug Research > Drug Delivery > News
See more Drug Delivery news

Latest Drug Delivery News and Insight

View all Drug Delivery news or find news targeted to your interests
Technology Platform
Including: Effervescent tables, effervescent granular in sachet, granular in sachets, orally disintegrating tablets, extended release tablets and soft gelatin capsules.
Drug Research > Drug Delivery > Products
A High Quality Formulation Development and Manufacturing Company
| By Alpex Pharma
Our predominant focus is the development of solid dosage forms to deliver drugs directly into the oral cavity in order to potentially improve both the bioavailablity of the drug as well as patient compliance and convenience to it. Alpex Pharma has 28 years of cGMP manufacturing experience and formulation development.
Drug Research > Drug Delivery > White Papers
The Medicines Company gets FDA approval for new formulation of Minocin for injection
By PBR Staff Writer
The Medicines Company (MDCO) has received approval from the US Food and Drug Administration (FDA) for its supplemental new drug application (sNDA) for a new formulation of Minocin (minocycline) for Injection.
Drug Research > Drug Delivery > News
Merck submits sBLA to FDA for Keytruda to treat NSCLC
By PBR Staff Writer
Merck has submitted a supplemental biologics license application (sBLA) to the US Food and Drug Administration (FDA) seeking approval for its anti-PD-1 therapy, Keytruda (pembrolizumab), to treat advanced non-small cell lung cancer (NSCLC).
Drug Research > Drug Delivery > News
Medimmune, Immunocore to evaluate melanoma immunotherapy combinations
By PBR Staff Writer
AstraZeneca's biologics research and development arm MedImmune has entered into a collaboration with UK-based biotechnology firm Immunocore to conduct clinical trials in immuno-oncology.
Drug Research > Drug Delivery > News
NewLink, Merck initiate Phase II/III Ebola trial in Sierra Leone
By PBR Staff Writer
NewLink Genetics and Merck have started the third, late-stage Phase II/III clinical trial (STRIVE) of their Ebola vaccine candidate rVSV-ZEBOV-GP (V920) in Sierra Leone.
Drug Research > Drug Delivery > News
Sagent launches Vancomycin hydrochloride for injection, USP
By PBR Staff Writer
US-based Sagent Pharmaceuticals has introduced Vancomycin Hydrochloride for Injection, USP, an anti-infective, in a 10g preservative-free pharmacy bulk package.
Drug Research > Drug Delivery > News
FDA accepts for filing Teva and Eagle's NDA for bendamustine rapid infusion product
By PBR Staff Writer
The US Food and Drug Administration (FDA) has accepted for filing Teva Pharmaceutical and Eagle Pharmaceuticals' new drug application (NDA) for a liquid bendamustine hydrochloride (HCl) rapid infusion product to treat patients with chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL).
Drug Research > Drug Delivery > News
View all Drug Delivery news or find news targeted to your interests